Vertex is also developing a version called VX ... which has a phase 1/2 trial on the go for islet cells in its proprietary Cell Pouch device. The first patient to receive that therapy has now ...

This week, Vertex announced a partnership with Lonza ... also recently reported positive results with its Cell Pouch islet cell transplant system, including insulin independence of between six ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...